These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 12921571)

  • 41. Effect of neoadjuvant chemotherapy on circumferential margin positivity and its impact on prognosis in patients with resectable oesophageal cancer.
    Sujendran V; Wheeler J; Baron R; Warren BF; Maynard N
    Br J Surg; 2008 Feb; 95(2):191-4. PubMed ID: 17948302
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Myelotoxicity of preoperative chemoradiotherapy is a significant determinant of poor prognosis in patients with T4 esophageal cancer.
    Miyoshi N; Yano M; Takachi K; Kishi K; Noura S; Eguchi H; Yamada T; Miyashiro I; Ohue M; Ohigashi H; Sasaki Y; Ishikawa O; Doki Y; Imaoka S
    J Surg Oncol; 2009 Apr; 99(5):302-6. PubMed ID: 19170110
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Improved local control by surgery and paclitaxel-based chemoradiation for esophageal squamous cell carcinoma: results of a retrospective non-randomized study.
    Hsu FM; Lin CC; Lee JM; Chang YL; Hsu CH; Tsai YC; Lee YC; Cheng JC
    J Surg Oncol; 2008 Jul; 98(1):34-41. PubMed ID: 18449912
    [TBL] [Abstract][Full Text] [Related]  

  • 44. REG I expression predicts long-term survival among locally advanced thoracic squamous cell esophageal cancer patients treated with neoadjuvant chemoradiotherapy followed by esophagectomy.
    Motoyama S; Sugiyama T; Ueno Y; Okamoto H; Takasawa S; Nanjo H; Watanabe H; Maruyama K; Okuyama M; Ogawa J
    Ann Surg Oncol; 2006 Dec; 13(12):1724-31. PubMed ID: 17009160
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Preoperative chemoradiotherapy prior to esophagectomy in elderly patients is not associated with increased morbidity.
    Rice DC; Correa AM; Vaporciyan AA; Sodhi N; Smythe WR; Swisher SG; Walsh GL; Putnam JB; Komaki R; Ajani JA; Roth JA
    Ann Thorac Surg; 2005 Feb; 79(2):391-7; discussionn 391-7. PubMed ID: 15680801
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prospective cohort comparison of neoadjuvant chemoradiotherapy versus chemotherapy in patients with oesophageal cancer.
    Morgan MA; Lewis WG; Crosby TD; Escofet X; Roberts SA; Brewster AE; Harvard TJ; Clark GW
    Br J Surg; 2007 Dec; 94(12):1509-14. PubMed ID: 17902093
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Treatment results of chemoradiotherapy for clinical stage I (T1N0M0) esophageal carcinoma.
    Yamada K; Murakami M; Okamoto Y; Okuno Y; Nakajima T; Kusumi F; Takakuwa H; Matsusue S
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1106-11. PubMed ID: 16504758
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Neoadjuvant treatment in surgery of esophageal cancer].
    Launois B; Raoul JL; Leprise E; Meunier B
    Bull Acad Natl Med; 2000; 184(8):1703-13; discussion 1714. PubMed ID: 11471389
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Phase III study comparing cisplatin plus fluorouracil to paclitaxel, cisplatin, and fluorouracil induction chemotherapy followed by chemoradiotherapy in locally advanced head and neck cancer.
    Hitt R; López-Pousa A; Martínez-Trufero J; Escrig V; Carles J; Rizo A; Isla D; Vega ME; Martí JL; Lobo F; Pastor P; Valentí V; Belón J; Sánchez MA; Chaib C; Pallarés C; Antón A; Cervantes A; Paz-Ares L; Cortés-Funes H
    J Clin Oncol; 2005 Dec; 23(34):8636-45. PubMed ID: 16275937
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Phase II study of cisplatin and 5-fluorouracil with concurrent radiotherapy in advanced squamous cell carcinoma of the esophagus: a Japan Esophageal Oncology Group (JEOG)/Japan Clinical Oncology Group trial (JCOG9516).
    Ishida K; Ando N; Yamamoto S; Ide H; Shinoda M
    Jpn J Clin Oncol; 2004 Oct; 34(10):615-9. PubMed ID: 15591460
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Neo-adjuvant chemoradiotherapy followed by surgery in treatment of advanced esophageal carcinoma].
    Yang H; Fu JH; Hu Y; Lin P; Liu MZ; Li Q; Fang ZC; Hu YH
    Zhonghua Yi Xue Za Zhi; 2008 Dec; 88(45):3182-5. PubMed ID: 19171088
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Correlation between histological effects on the main tumors and nodal status after chemoradiotherapy for squamous cell carcinoma of the esophagus.
    Yano M; Yasuda T; Miyata H; Fujiwara Y; Takiguchi S; Monden M
    J Surg Oncol; 2005 Mar; 89(4):244-50; discussion 250. PubMed ID: 15726612
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Postoperative adjuvant cisplatin, vindesine, plus uracil-tegafur chemotherapy increased survival of patients with completely resected p-stage I non-small cell lung cancer.
    Imaizumi M;
    Lung Cancer; 2005 Jul; 49(1):85-94. PubMed ID: 15949594
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Retrospective study of chemoradiotherapy based on cisplatin compared with radiotherapy alone for cervical cancer].
    Han C; Kong WM
    Zhonghua Fu Chan Ke Za Zhi; 2007 Nov; 42(11):723-6. PubMed ID: 18307894
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Influence of number of metastatic lymph nodes on survival of curative resected thoracic esophageal cancer patients and value of radiotherapy: report of 549 cases.
    Xiao ZF; Yang ZY; Miao YJ; Wang LH; Yin WB; Gu XZ; Zhang DC; Sun KL; Chen GY; He J
    Int J Radiat Oncol Biol Phys; 2005 May; 62(1):82-90. PubMed ID: 15850906
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Salvage surgery after failed chemoradiotherapy in squamous cell carcinoma of the esophagus.
    Chao YK; Chan SC; Chang HK; Liu YH; Wu YC; Hsieh MJ; Tseng CK; Liu HP
    Eur J Surg Oncol; 2009 Mar; 35(3):289-94. PubMed ID: 18396384
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Phase III trial of protracted compared with split-course chemoradiation for esophageal carcinoma: Federation Francophone de Cancerologie Digestive 9102.
    Crehange G; Maingon P; Peignaux K; N'guyen TD; Mirabel X; Marchal C; Verrelle P; Roullet B; Bonnetain F; Bedenne L;
    J Clin Oncol; 2007 Nov; 25(31):4895-901. PubMed ID: 17971585
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Treatment outcomes for radiotherapy alone are comparable with neoadjuvant chemotherapy followed by radiotherapy in early-stage nasopharyngeal carcinoma.
    Song CH; Wu HG; Heo DS; Kim KH; Sung MW; Park CI
    Laryngoscope; 2008 Apr; 118(4):663-70. PubMed ID: 18216741
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Evaluation of neoadjuvant chemotherapy for locally advanced cervical cancinoma].
    Cheng XD; Lü WG; Ye F; Chen HZ; Xie X
    Zhonghua Fu Chan Ke Za Zhi; 2006 Feb; 41(2):95-8. PubMed ID: 16640856
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.